Latest News

Asian patients with psoriasis have shortest visits, study shows


 

FROM JAMA DERMATOLOGY

Other differences found

In addition to visit length, they found significant differences in mean age and in the use of complex topical regimens. The mean ages of Asian, Hispanic or Latino, and non-Hispanic Black patients were 37.2, 44.7, and 33.3 years, respectively. Complex topical regimens were prescribed to 11.8% of Asian patients, compared with 1.5% of Black and 1.1% of White patients.

For practicing dermatologists, knowing for now that Asian patients have shorter visits “may bring to light some consciousness to how we practice,” Dr. Yang noted. “We may counsel differently, we may spend differing amounts of time – for reasons still unknown. But being generally aware can help us to shift any unconscious bias that may be there.”

Dermatologists, Dr. Armstrong and Dr. Wu wrote, “need to allow sufficient time to develop strong physician-patient communication regardless of patient background.”

The NAMCS – administered by the Center for Disease Control and Prevention’s National Center for Health Statistics – collects data on a sample of visits provided by non–federally employed office-based physicians.

Dr. Armstrong disclosed receiving personal fees from AbbVie and Regeneron for research funding and serving as a scientific adviser and speaker for additional pharmaceutical and therapeutic companies. Dr. Wu, Dr. Scott, and Dr. Yang did not report any disclosures.

Pages

Recommended Reading

Large study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBD
MDedge Family Medicine
Zoster vaccination does not appear to increase flare risk in patients with immune-mediated inflammatory disease
MDedge Family Medicine
Physicians urged to write indications on drug scripts as methotrexate users face new barriers with SCOTUS decision
MDedge Family Medicine
Methotrexate’s impact on COVID-19 vaccination: New insights made
MDedge Family Medicine
NAFLD strongly correlated with psoriasis, PsA; risk linked to severity
MDedge Family Medicine
Questionnaire for patients with psoriasis might identify risk of axial involvement
MDedge Family Medicine
Topical roflumilast approved for psoriasis in adults and adolescents
MDedge Family Medicine
Study suggests psoriasis and PsA are underdiagnosed in underserved groups
MDedge Family Medicine
Biosimilar-to-biosimilar switches deemed safe and effective, systematic review reveals
MDedge Family Medicine
FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration form
MDedge Family Medicine